StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research note released on Thursday morning. The brokerage issued a hold rating on the stock.
China Pharma Price Performance
Shares of NYSE CPHI opened at $0.21 on Thursday. The stock’s 50-day moving average is $0.20 and its 200 day moving average is $0.22. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. China Pharma has a 1-year low of $0.13 and a 1-year high of $0.60.
About China Pharma
Read More
- Five stocks we like better than China Pharma
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Learn Technical Analysis Skills to Master the Stock Market
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
